We’ve all heard the pros and cons of the industry’s outlook in Europe, the US and some Asian nations, but information from South America and Southeast Asia can be scarce. However, new data suggests that opportunity may lie in two countries, one that has been mostly overlooked and one at the forefront of global headlines.
The new data provide insight into the growing global market for pharma. EyeForPharma, an industry hub led by senior level executives, highlighted these two markets, as well as the markets of several countries across the globe.
One of the goals we strive for at my Washington, D.C.-based health communications firm, Spectrum, is flawless performance for clients. We invest the time to ensure that we completely understand our clients’ needs in the U.S. marketplace, and design creative, strategic plans grounded in science and research. We then move forward with every expectation of “smooth sailing.”